Brief: Creso Pharma And Red Light Holland Entered Definitive Agreement To Merge Their Businesses
17/06/2021 02:35
June 17 (Reuters) - Creso Pharma Ltd CPH.AX :
* CRESO PHARMA AND RED LIGHT HOLLAND HAVE ENTERED INTO A
DEFINITIVE AGREEMENT TO MERGE THEIR BUSINESSES AND CREATE
HIGHBRID LAB
* HIGHBRID LAB IS EXPECTED TO HAVE AN IMPLIED PRO FORMA
EQUITY
VALUE OF A$371 MILLION
* BRUCE LINTON EXPECTED TO JOIN AS NON-EXECUTIVE CHAIRMAN OF
HIGHBRID LAB'S BOARD OF DIRECTORS
* ONCE MERGED, HIGHBRID LAB TO COMMENCE SELLING ITS ANIMAL
AND
HUMAN CBD PRODUCTS WITHIN USA
* HIGHBRID LAB WILL TRADE ON CANADIAN SECURITIES EXCHANGE
UNDER
TICKER SYMBOL 'TRIP'
Source text for Eikon: urn:newsml:reuters.com:*:nASX7N6LNk
Further company coverage: CPH.AX
((Reuters.Briefs@thomsonreuters.com;))